Hepatic cryotherapy is a relatively new technique, currently employed in the treatment of un resectable liver malignancy, which involves directJreezing of tumour deposits with liquid nitrogen. In a review of26 patients undergoing this procedure, the anaesthetic considerations are defined. The total operation time rangedfrom 133 to 410 minutes. In spite of preventative measures, varying degrees of hypothermia occurred (range 33.7" C to 36.5· C), but no sequelae were encountered. Mean blood loss was 926 ml, and eleven patients required blood transfusion of between one and five units. There was a marked drop in platelet count associated with cryotherapy (mean fall of 123,OOO/mm 1 by the second postoperative day). Following the procedure, fever and basal pulmonary atelectasis were common, while hypoglycaemia and renal impairment occurred on single occasions. Six patients underwent postoperative mechanical ventilation. Despite this, the mean hospital stay was under seven days.
Colorectal cancer is the commonest cause of cancer death in nonsmokers and liver metastases are present in up to 80% of patients dying of this disease. I Hepatic resection offers a 20 to 25% fiveyear survival 2 ,3 in patients with metastases. However, in only a fraction of these is surgery feasible, 3 owing to factors such as poor patient condition, bi-Iobar disease, involvement of unresectable structures or the sheer number of secondary lesions.
With no treatment, the prognosis is extremely poor. 4 Systemic chemotherapy for colorectalliver metastases has proved to be disappointing, although intrahepatic arterial infusion of cytotoxics produces a better response rate. 5 Clearly, a technique that would permit the focal destruction of hepatic secondaries while preserving normal tissue would be a major advance.
Cryotherapy involves direct freezing of lesions which then undergo coagulative necrosis, in time leaving only a contracted fibrotic mass. At temperatures below _20· C, most cells die as a direct consequence of internal freezing, of secondary vascular thrombosis or of exposure to concentrated electrolytes during thawing. 6 The idea of cyrotherapy is not new,1 but only recently has it found application in the treatment of hepatic tumours. 6 ,S-1O To date, our institution has been the only one in Australia utilising this technique in the management of hepatic malignancy, mostly of colorectal origin. The anaesthetic considerations have not been previously reported.
METHODS

Patients
A retrospective analysis was performed on the anaesthetic and operative data of 26 patients (22 male, 4 female) undergoing cyrotherapy between April 1990 and July 1991. No patient had unresectable extrahepatic disease and all had unresectable liver malignancy. One male patient underwent a second operation ten months after his first for treatment of a solitary recurrence and both operations are included in the analysis. The mean age was 58 years (range 30-72) and mean weight 77 kg (range 47-105 kg).
Preoperatively, nine patients were classified ASA I, eight were ASA 11 and nine patients ASA Ill. Twenty-four patients were treated for metastatic colonic carcinoma, one for a hepatoma and one for metastatic malignant melanoma.
In addition to the cyrotherapy, 19 patients had a cholecystectomy, 21 patients had a hepatic artery catheter inserted, four had wedge resections of tumour tissue and two underwent synchronous resection of primary colonic carcinoma.
Operative procedure
The abdomen is opened via a roof-top incision, and the liver is examined, both directly and with intraoperative ultrasound, to delineate the position and number of lesions. Intraoperative ultrasound has been demonstrated to be highly sensitive in this respect. I I A specially designed spike cyroprobe with an insulated shaft is passed through liver tissue under ultrasound control, to position the tip within the nodule to be frozen. At the tip of the probe, liquid nitrogen is circulated at -196° C, generating an iceball, the size of which can be monitored with the ultrasound, and appearing as a dark (hypoechoic) area. 9 Freezing is continued until the diameter of the ice ball is 1 cm greater than that of the metastasis.
Thawing is achieved by the passage of warmed nitrogen gas through the probe tip.12 It is at this point that the iceball may 'crack', leaving a fissure in the liver. This is usually managed with Gelfoam and a haemostatic suture. Once thawing is complete, the probe is removed and the tract remaining is packed with Gelfoam.
In the absence of extrahepatic malignant disease, a silastic indwelling hepatic artery catheter is inserted via the gastroduodenal artery and bi-Iobar perfusion confirmed by injecting methylene blue dye. An injection port is placed subcutaneously, permitting regional chemotherapy to be administered postoperatively. Cholecystectomy and ligation of the right gastric artery is routinely performed to prevent cytotoxic cholecystitis and peptic ulceration.
Anaesthetic technique
Each patient received a routine preoperative workup, including ECG, chest X-ray, haematological and biochemical profiles and blood crossmatch.
Premedication was at the discretion of the anaesthetist, and of the 26 patients, 23 received an opioid-based premedication. Each patient received a general anaesthetic and in all cases, a nitrous oxide/oxygen, volatile agent (enflurane or isoflurane) and relaxant technique was used. Eleven patients received intraoperative opioids.
A radial arterial line and nasopharyngeal thermistor probe were inserted in all cases, and in all but one an internal jugular venous line. Monitoring included ECG, SpOb capnography, urine output, direct arterial blood pressure (BP), central venous pressure (CYP) and nasopharyngeal temperature. Blood loss was estimated by sponge weight and direct measure. Capillary blood sugar level (BSL) was checked once intraoperatively.
A blood warmer, heated mattress and cotton blankets were used to preserve body heat. Reflective blankets were used in six patients, while a heat and moisture exchanger (HME) or heater humidifier was used in 20 and 19 patients respectively.
Patients were managed immediately postoperatively in our high dependency unit (HDU), or in the intensive care unit (lCU) when postoperative mechanical ventilation was utilised. A pethidine infusion was used to provide analgesia in 20 patients and the remaining six received other forms of parenteral analgesia.
Statistical analysis: perioperative platelet counts
An unexpected fall in postoperative platelet counts was noted in patients undergoing cryotherapy. We compared this with the perioperative platelet counts of nine patients undergoing hepatic artery cannulation alone, which requires an identical incision to that used for hepatic cryotherapy, and eighteen patients undergoing hemicolectomy, which also entails a major laparotomy. The mean falls from the preoperative count to those of day 1 and day 2 postoperatively were compared by single factor analysis of variance (ANOYA).
RESULTS
Operative data
The mean duration of the total procedure was 272 minutes (range 133-410 minutes). Between one and nine metastases were treated per patient, ranging in size from 0.5 to 12 cm diameter. The mean duration of active freezing was 70 minutes (range 6-199 minutes). In eight patients, 'cracking' of the iceball occurred during thawing, and five of these required blood transfusion of between one and four units. One of these patients required abdominal packs to be left in situ overnight.
Anaesthetic data
The mean lowest nasopharyngeal temperature recorded was 35.2° C (range 33.7"-36.5"). There appeared to be no relationship between duration of surgery or total freeze time and the lowest recorded body temperature ( Figure I) .
Mean blood loss was 926 ml (range 300-1860). All patients received an infusion of Hartmann's solution, the mean requirement being 2188 ml (range 1000-4000). Between 500-800 ml of SPPS was received by five patients, and between 500-1500 ml of Haemaccel by 14 patients. Eleven patients required blood transfusion of between one and five units, seven of these received two or less units. There were no episodes of intraoperative hypoglycaemia recorded.
Haematologicallbiochemical data
The perioperative haematological and biochemical profiles of each patient are illustrated in Figure 2 . There was a dramatic fall in postoperative platelet counts in all our patients, falling from a mean preoperative level of 290,000/ cubic millimetre to 193,000 and 168,000 on postoperative days 1 and 2 respectively. The mean fall in platelet count on day 1 and day 2 postoperatively in the cyrotherapy group was significantly greater than that recorded in the hepatic artery cannulation and hemicolectomy groups ( Table 1) . The mean haemoglobin level fell from a preoperative value of 136 g/Iitre to 128 and 119 gllitre on postoperative days 1 and 2 respectively.
The mean preoperative serum total bilirubin rose from 11 l1mol/litre to 28 l1mol/litre on day 1 and 23 l1mol/litre on day 2, and over the same time period, mean serum albumin fell from 43 g/Iitre to 34 gllitre and 32 g/Iitre respectively. A marked increase in serum aspartate amino transferase (AST) occurred, climbing from a mean preoperative level of 32 international units (IV)/ litre, to 682 IVnitre on day 1 and tailing off to 191 IVnitre on day 2. The mean creatinine level throughout this period remained steady at 0.1 mmol/litre.
Postoperative data
The mean in hospital stay was 6.8 days (range 3-15 days). Six patients underwent elective mechanical ventilation for no longer than 12 hours for reasons of hypothermia, long procedure or large blood loss. The longest ICV stay was two days, and even this patient was discharged from hospital on the seventh postoperative day. The patient who required a fifteen-day hospitalisation had developed mild postoperative cholestatic jaundice and pulmonary atelectasis, but was permitted 'day leave' from day 10 post operation.
Following cyrotherapy, pyrexia (defined as a temperature in excess of 38° C for greater than 12 hours) developed in 14 of the 26 patients. Basal atelectasis on chest radiograph occurred in 10 patients. One patient, a 70-year-old male with a preoperative creatinine of 0.15 mmol/litre, had a 
DISCUSSION
Our own results l2 and those of other groups6, 8, 9, 13 have demonstrated hepatic cyrotherapy as a technique with an acceptable morbidity, and in our experience, no mortality, for the treatment of unresectable metastatic liver disease and primary tumours. Its role in palliation and improvement in survival is currently under investigation, but preliminary results are promising. In the series by Onik, 13 22% of patients were in complete remission for between 11 and 60 months, and the mean survival in those patients with disease recurrence or incomplete treatment at the time of cryosurgery was 21.4 months. In the treatment of primary liver cancer, Zhou 8 has claimed a 37.5% five-year survival in patients with tumour nodules less than 5 cm diameter.
The main intraoperative problems to be dealt with are hypothermia and its consequences, blood loss, hypoglycaemia and prolonged surgery. Postoperatively, renal impairment and respiratory complications may occur. Apart from the problems of cryotherapy itself, the possibility is always present that hepatic resection that was not initially anticipated may be required. For these reasons, an aggressive approach to monitoring, fluid therapy and maintenance of body temperature is used.
Although each patient developed some degree of hypothermia (mean lowest temperature of 35.2·C), no sequelae were encountered, even in one patient in whom the temperature fell as low as 33.7· C. The duration of the actual tissue freeze or operation time did not appear to have any direct bearing on the degree of hypothermia. The determinant therefore, may lie in individual variations in body shape, fat content and metabolic rates, although the relative position of the cryoprobe to major vessels, which might lead to direct cooling of blood, may contribute. Our surgeon (DLM) has had prior experience with a patient who developed significant arrhythmias during cryotherapy, possibly due to a cold stream of blood returning to the heart, direct myocardial cooling or a sudden potassium load from cell lysis.
Mean blood loss in our series was 926 ml, and in no patient was this sudden or uncontrolled. Bleeding was heavier in situations where 'cracking' of the iceball occurred.
We feel that attention to intraoperative hydration, fluid replacement and maintenance of urine output is importannt in avoiding postoperative renal dysfunction reported by Onik. 13 In that series, 3 out of 18 patients developed ATN (none requiring dialysis), and myoglobinuria was demonstrable in seven. Only one patient in our series, who had pre-existing renal impairment, developed a deterioration in renal Anaesthesia and Intensive Care, Vol, 10, No, 4, November, 1991 function, and myoglobinuria was not detected in any of five consecutive patients tested for this. Patients with preoperative renal impairment may benefit from induced diuresis with mannitol. 13 A general tendency for platelet numbers to fall postoperatively, with a concomitant rise in adhesiveness, has been previously described. 14 However, we have found that there was a greater than expected fall following cryotherapy compared with other patients with comparable incisions and disease process. We can only speculate that there may be a greater degree of platelet sequestration in reticulo-endothelial organs immediately following hepatic cryotherapy. Apart from this finding, the perioperative changes in haematological and biochemical parameters we have documented are as to be expected. The fall in serum albumin levels postoperatively may reflect an impairment in the hepatic biosynthetic processes, while the slight rise in total serum bilirubin may be due to localised intrahepatic cholestasis. A rise in AST correlates with destruction of hepatic tissue and release of this intracellular enzyme.
Postoperatively, adequate analgesia was provided with an opioid infusion, which in the HDU environment could be readily titrated to the patients' needs. As in other series, 8 pyrexia was a common finding, and in most instances no focus of infection was isolated. Ten of our patients developed basal pulmonary atelectasis which in all cases resolved with aggressive physiotherapy. This may account for some of the recorded pyrexia. In contrast, Onik l3 found that nearly all their patients developed asymptomatic pleural effusions, and one patient developed an hepatic abscess. A single subphrenic abscess was also reported in the series by Ravikumar. 1O The only episode of hypoglycaemia recorded occurred postoperatively in a patient who had undergone previous hepatic resection. In this case, the significantly reduced hepatic mass probably led to an impairment in glucose homeostasis. Although hypoglycaemia has not been a problem in our experience, we believe a spot check intraoperatively and routine monitoring postoperatively to be advisable.
In spite of the seemingly hazardous nature of applying sub-zero temperatures to large areas of vital tissue, the anaesthetic problems have been few. The mean hospital stay of 6.8 days is testament to the concept that cryotherapy is a procedure well tolerated by most patients, with a low overall morbidity. Although the procedure aims to minimise tissue destruction and physiological insult, the anaesthetic contribution to perioperative patient outcome cannot be overstated. Careful attention to basic principles such as minimizing heat loss, optimal fluid management and appropriate postoperative care is required to avoid the complications already alluded to, and to maintain the technique of hepatic cryotherapy as a viable and safe treatment option in the management of unresectable liver malignancy.
